Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States
Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States
复制标题
DOI：
10.1080/21645515.2018.1467203
复制
发表时间：
2018-01-01
影响因子：
4.8
通讯作者：
Osazuwa-Peters, Nosayaba
中科院分区：
文献类型：
--
作者：
Boakye, Eric Adjei;Lew, Daphne;Osazuwa-Peters, Nosayaba
目的：研究具有全国代表性的 18-26 岁成年人样本中 HPV 疫苗接种率的相关性。方法：从 2014 年和 2015 年国家健康访谈调查中确定了 18-26 岁的年轻人（n = 7588）。调查加权多变量逻辑回归模型估计了与 HPV 疫苗接种（>= 1 剂）和完成（>= 3 剂）相关的社会人口统计学因素。结果：大约 27% 的研究参与者已开始接种 HPV 疫苗，16% 已完成 HPV 疫苗。如果参与者是男性，则开始接种疫苗的可能性较小[（调整后的比值比）0.19； （95% 置信区间）0.16-0.23），与大学毕业生相比，拥有高中文凭（0.40；0.31-0.52）或更少（0.46；0.320.64），并且出生在美国境外（0.52；0.40-0.69）。但是，如果参与者在过去 12 个月内去看医生 1-5 次 (2.09; 1.56-2.81) 或 >= 6 次 (1.86; 1.48-2.34)，则与没有去看医生的参与者相比，更有可能开始接种 HPV 疫苗。完成 HPV 疫苗接种的几率与开始接种的几率相同。在按性别和外国出生状况对研究人群进行分层后，这些变量仍然具有统计显着性。 结论：在我们具有全国代表性的研究中，只有六分之一的 18-26 岁人群完成了所需的疫苗剂量。男性、受过高中或以下教育的人以及在美国境外出生的人开始并完成 HPV 疫苗接种的可能性较小。我们的研究结果表明，制定有针对性的干预措施以促进追赶年龄范围内的人接种 HPV 疫苗可能会有所帮助。
Purpose: To examine correlates of HPV vaccination uptake in a nationally representative sample of 18-26-year-old adults.Methods: Young adults aged 18-26 years were identified from the 2014 and 2015 National Health Interview Survey (n = 7588). Survey-weighted multivariable logistic regression models estimated sociodemographic factors associated with HPV vaccine initiation (>= 1 dose) and completion (>= 3 doses).Results: Approximately 27% of study participants had initiated the HPV vaccine and 16% had completed the HPV vaccine. Participants were less likely to initiate the vaccine if they were men [(adjusted odds ratio) 0.19; (95% confidence interval) 0.16-0.23), had a high school diploma (0.40; 0.31-0.52) or less (0.46; 0.320.64) vs. college graduates, and were born outside the United States (0.52; 0.40-0.69). But, participants were more likely to initiate the HPV vaccine if they visited the doctor's office 1-5 times (2.09; 1.56-2.81), or >= 6 times (1.86; 1.48-2.34) within the last 12 months vs. no visits. Odds of completing HPV vaccine uptake followed the same pattern as initiation. And after stratifying the study population by gender and foreign-born status, these variables remained statistically significant.Conclusions: In our nationally representative study, only one out of six 18-26 year olds completed the required vaccine doses. Men, individuals with high school or less education, and those born outside the United States were less likely to initiate and complete the HPV vaccination. Our findings suggest that it may be useful to develop targeted interventions to promote HPV vaccination among those in the catch-up age range.